‌

US Patent 10131627 Heterodimers of glutamic acid

Patent 10131627 was granted and assigned to Molecular Insight Pharmaceuticals, Inc. on November, 2018 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Patent Applicant

‌

Molecular Insight Pharmaceuticals, Inc.

Current Assignee

‌

Molecular Insight Pharmaceuticals, Inc.

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

10131627

Patent Inventor Names

Kevin P. Maresca0

Craig N. Zimmerman0

John W. Babich0

Date of Patent

November 20, 2018

Patent Application Number

15794539

Date Filed

October 26, 2017

Patent Citations Received

‌

US Patent 10640461 Heterodimers of glutamic acid

‌

US Patent 10647666 Heterodimers of glutamic acid

Patent Primary Examiner

‌

Marcos L Sznaidman

Patent abstract

Compounds of Formula (Ia)

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10131627 Heterodimers of glutamic acid

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API